Depressed Jane

Let Me Tell You More About My Depressed, Miserable Existence

Archive for April, 2009

Frequent Mental Distress (FMD), defined as having 14 or more days in the previous month when stress, depression and emotional problems were not good , is not evenly distributed across the United States. In fact, certain geographic areas have consistently high or consistently low FMD incidence, as shown in a study published in the June 2009 issue of the American Journal of Preventive Medicine.

Popularity: unranked [?]

A new US study found that patients with heart disease who were then diagnosed with depression were at greater risk of heart failure, and that taking antidepressants neither reduced the risk of heart failure, a condition where the heart can’t pump enough blood for the body, nor eased the symptoms of depression.

Popularity: 1% [?]

Psychiatrists and critical care specialists at Johns Hopkins have begun to tease out what there is about a stay in an intensive care unit (ICU) that leads so many patients to report depression after they go home.

Popularity: 8% [?]

IntelGenx Corp. (TSX:IGX)(OTCBB:IGXT) (“IntelGenx”) and Cary Pharmaceuticals Inc. (“Cary Pharma”) today announced that a New Drug Application (“NDA”) has been submitted to the U.S. Food and Drug Administration (“FDA”) for their antidepressant CPI-300, a new strength of a leading antidepressant that will provide a more convenient dosing option to patients with major depressive disorder (“MDD”).

Popularity: unranked [?]

Poor team spirit in the workplace boosts an employee’s risk of depression, and subsequent use of antidepressants, finds research published ahead of print in Occupational and Environmental Medicine. The findings are based on a nationally representative sample of 3,347 Finnish employees, all of whom were aged between 30 and 64.

Popularity: unranked [?]

IntelGenx Corp. (TSX:IGX)(OTCBB:IGXT) (“IntelGenx”) and Cary Pharmaceuticals Inc. (“Cary Pharma”) today announced that a New Drug Application (“NDA”) has been submitted to the U.S. Food and Drug Administration (“FDA”) for their antidepressant CPI-300, a new strength of a leading antidepressant that will provide a more convenient dosing option to patients with major depressive disorder (“MDD”).

Popularity: unranked [?]

Dr. Jeffrey Meyer, and Head of Neurochemical Imaging in the Mood Disorders at the Centre for Addiction and Mental Health (CAMH), is the first psychiatrist to be honoured with the Royal College Medal Award in Medicine in the award’s 60 year history. For over 30 years, scientists believed that monoamines – mood-related chemicals such as serotonin, norepinephrine and dopamine – are low in the brain during episodes of major depression.

Popularity: unranked [?]

A new study points to a troubling connection between out-of-pocket expenses for people contending with both physical illnesses and depression, affecting access to antidepressant treatment. Dr.

Popularity: unranked [?]

Dr. Jeffrey Meyer, and Head of Neurochemical Imaging in the Mood Disorders at the Centre for Addiction and Mental Health (CAMH), is the first psychiatrist to be honoured with the Royal College Medal Award in Medicine in the award’s 60 year history. For over 30 years, scientists believed that monoamines – mood-related chemicals such as serotonin, norepinephrine and dopamine – are low in the brain during episodes of major depression.

Popularity: unranked [?]

Instruments that are intended to measure change over time need to emphasize sensitivity to change as a central property. The aims of this report are to test whether the MOODS-SR, a measure of mood spectrum symptomatology, is sensitive to changes during acute and continuation treatment of depression and whether residual mood spectrum symptoms predict relapse in the subsequent 6 months.

Popularity: unranked [?]